Embed Size (px)
Citation preview
（痔疮）
（便秘）
（消化不良）
（胆石症）
（疝气）
（肠易激综合征）
（胃炎）
（消化性溃疡）
2
Gastrointestinal drugs
1. Drugs used for acid-peptic
disorders
2. Modulators of gastrointestinal
functions
3
Acid-peptic disorders
1) Peptic ulcer disease (PUD)
2) Gastroesophageal reflux disease (GERD)
4) Drug-induced mucosal injury, especially by non-steroidal anti-inflammatory drugs (NSAIDs)
3) Pathologic acid-hypersecretory conditions (e.g. Zollinger-Ellison syndrome)
5) Acute stress ulcers
4
Drugs used for peptic ulcers
Mucus-bicarbonate barrier
5
Helicobacter pylori infection 6
Marshall BJ Warren JR
The Nobel prize in 2005: for their discovery of the bacterium Helicobacter pylori and its role in gastritis and peptic ulcer disease
7
Pathogenesis of peptic ulcers
Treatment approaches
(1) Increased gastric acid secretion
(3) Inadequate mucosal defense against gastric acid
(2) Infection with Helicobacter pylori
(1) Reduce secretion of gastric acid or neutralizing the acid
(3) Protect the gastric mucosa from damage
(2) Eradicate 根除 H. pylori infection
8
(1) Antacids: neutralize 中和 the acid
(2) Drugs suppressing gastric acid secretion
① H2 receptor antagonists
② H+-K+-ATPase inhibitors (proton pump inhibitors)
③ Muscarinic receptor antagonists
④ Gastrin receptor antagonists
(3) Mucosal protective drugs
(4) Antimicrobial drugs (Helicobacter pylori)
Drugs used for peptic ulcers
9
Antacids (weak bases)
Chemistry of antacids:
Aluminum salts (aluminum hydroxide)
Magnesium salts (carbonate, hydroxide or oxide)
Calcium salts (carbonate)
Sodium salts (bicarbonate)
10
1. Pharmacological effects
- Neutralize gastric acid, diminishing gastric acidity and
inactivating pepsin （胃蛋白酶） - Form a protective membrane on the gastric mucosa
- Depend on the dose and dosing frequency.
- Effect starting within 5-15 min, lasting 1-3 h.
2. Clinical uses
Commonly used for minor episodes of heartburn.
Antacids (weak bases)
11
3. Adverse effects
(1) Constipation and stomach cramp (Al/Ca salts )
(2) Diarrhea (Mg salts)
(3) Hypercalcium (calcium salts)
(4) Hypernatremia (sodium salts)
4. Drug interactions
Affect rates of dissolution and absorption,
bioavailability, and renal elimination of many drugs
Antacids (weak bases)
12
NOTICE
(1) Take antacids 1 hour after meals
Four times a day after meals and at bedtime.
(2) Should not be taken continuously for more than 2
weeks
(3) To avoid or reduce drug interaction, other medication
should be taken 1-2 hours after taking an antacid
13
× AntacidsProton pump inhibitors×
H2 receptor antagonists
×
M receptor antagonists ×
Gastrin receptor antagonists
×
Drugs that suppress gastric acid secretion
14
Cimetidine
西咪替丁，甲腈咪胍
NNN
CH2SCH2CH2NHCNHCH3
H
H3C
CN
H2 receptor antagonists
15
1. Pharmacological effect
Blocks H2 receptors, decreases H+ and pepsin
secretion, promotes ulcer healing.
2. Clinical uses
1) Duodenal and gastric ulcer （ high rate of
relapse ） 2) Zollinger-Ellison syndrome
3) Acute stress ulcers
4) Gastroesophageal reflux disease (heartburn)
5) Decreased immune function
Cimetidine
16
3. Adverse effects (1) common side effects: constipation, diarrhea,
tiredness, muscular pain, etc.
(2) CNS effects: headache, dizziness, confusion,
hallucination, etc. (elderly, long-term uses)
(3) Antiandrogen （抗雄激素） effects
4. Drug interactions Inhibits hepatic P450, raises plasma concentrations of
warfarin, phenytoin, diazepam, propranolol, quinidine
and theophylline, etc.
Cimetidine
17
Other H2 receptor antagonists
Ranitidine ( 雷尼替丁 )
4 ～ 10 times more potent than cimetidine; Minimal side effects, weakly inhibits CYP
Famotidine ( 法莫替丁 )
40-50 times more potent than cimetidine; no inhibition of CYP
Nizatidine ( 尼扎替丁 )
High bioavailability (nearly 100%)18
Omeprazole 奥美拉唑，洛赛克
N
OCH3H3C CH3
CH2
OCH3
S
O
H
N
N
H+-K+-ATPase inhibitors
19
1. Pharmacological effects(1) Inhibits gastric acid secretion induced by various
stimuli (histamine, gastrin, aspirin, ethanol, stress)
(2) Inhibits H. pylori
2. Clinical uses(1) Highly effective for duodenal and gastric ulcer, reflux
esophagitis: relieves symptoms, promotes healing of
ulcers
(2) Used with antimicrobial regimens to eradicate H.
pylori
Omeprazole
20
3. Adverse effects
(1) Side effects: nausea, headache, diarrhea, constipation
and rash (rare)
(2) Increase of gastric carcinoid tumor: prolongated
hypochlorhydria 胃酸过少症 and secondary
hypergastrinemia 高胃泌素症(3) Others: gynecomastia (男性乳房发育 ), hypersensitivity
4. Drug interactions
Inhibits hepatic P450, raises plasma concentrations of
warfarin, phenytoin, diazepam, etc.
Omeprazole
21
Other proton pump inhibitorsOther proton pump inhibitors
22
Pirenzepine 哌仑西平
M and gastrin receptor antagonists
23
Proglumide
丙谷胺
Mucosal protective drugs
Effects: Protect the gastric and duodenal mucosa from damage by acid and pepsin
Misoprostol 米索前列醇Sucralfate 硫糖铝Colloidal bismuth subcitrate 胶体次枸橼酸铋
24
OHCH3OCH3
O O
HO
Mucosal protective drugs
Misoprostol 米索前列醇
A prostaglandin E (PGE) analogues
25
Misoprostol 米索前列醇
1. Pharmacological effects Inhibits gastric acid secretion
Promotes mucus and HCO3- secretion, mucosal repair
2. Clinical uses Approved for the prevention of NSAIDs-induced gastric
ulcer.
3. Adverse effects Side effects (13%): abdominal pain, diarrhea, headache,
nausea, etc.
Contraindicated in pregnancy women: Abortifacient ( 堕胎 ) effect
26
Sucralfate ( 硫糖铝 )
A sulfated disaccharide （硫酸蔗糖） complex of aluminum hydroxide
Mucosal protective drugs
27
1. Pharmacological effects
1) Binds to tissue proteins and forms a protective barrier
2) Enhances cell restitution修复 and re-epithelization重上皮化3) Weakly inhibits H.Pylory growth.
2. Clinical uses and adminstration
Peptic ulcers
Take sucralfate 1 hour before meals
Four times a day before meals and at bedtime
3. Adverse effects
Constipation occurs in 2% due to the aluminum salt
Sucralfate
28
Bismuth Compounds 铋制剂Colloidal bismuth subcitrate (CBS, 胶体次枸橼酸铋 )
Bismuth subsalicylate 次水杨酸铋
1. Pharmacological effects
1) Probably coats ulcers and erosions, creating a
protective layer against acid and pepsin
2) Stimulates prostaglandin, mucus, and bicarbonate
secretion
3) Kills H. pylori
Mucosal protective drugs
29
2. Clinical uses
1) Nonspecific treatment of peptic ulcers, dyspepsia and
acute diarrhea.
2) Used in multidrug regimens for the eradication of H
pylori infection.
3. Adverse effects
Causes blackening of the stool
Bismuth toxicity resulting in encephalopathy ( 脑病， ataxia, headaches, confusion, seizures)- used for
short period and contraindicated in patients with renal
insufficiency.
Bismuth Compounds
30
Teprenone （替普瑞酮）Marzulene-S （麦滋林 -S）Smectite （蒙脱石，思密达）
Other mucosal protective drugs
31
Antimicrobial drugs (for Helicobacter pylori)
1. Anti-ulcer drugs H+-K+-ATPase inhibitors; bismuth; sulralfate 硫糖铝 Weaker, combined with antimicrobial drugs
2. Antibiotics metronidazole (甲硝唑 ); amoxicillin (阿莫西林 );
tetracycline (四环素 ); gentamicin (庆大霉素 );
clarithromycin (克拉霉素 )
32
The best treatment regimen consists of a 10-14 day regimen of "triple therapy":
1) Bismuth subsalicylate (2 tablets; 262 mg each),2) Tetracycline (500 mg), 3) Metronidazole (250 mg), each taken four times daily for 14 days.
Program 2
Program 1
1) A proton pump inhibitor twice daily, 2) Clarithromycin 500 mg twice daily, 3) Amoxicillin 1 g twice daily. For patients who are allergic to penicillin, metronidazole 500 mg twice daily should be substituted for amoxicillin.
33
1) A proton pump inhibitor twice daily
2) Bismuth subsalicylate (2 tablets; 262 mg each),
3) Tetracycline (500 mg),
4) Metronidazole (250 mg), each taken four times
daily for 14 days.
For patients with resistant infections, "quadruple therapy”
34
Gastrointestinal drugs
1. Drugs used for acid-peptic disorders
2. Modulators of gastrointestinal
functions
35
Abnormalities of gastrointestinal functions
Nausea and vomiting
ConstipationDiarrhea 36
Dyspepsia
Modulators of gastrointestinal functions
1. Digestants （助消化药）
2. Antiemetics （止吐药）
3. Prokinetic drugs ( 胃肠动力药 )
4. Anti-diarrheals （止泻药）
5. Laxatives （泻药）
6. Choleretics （利胆药）
37
Modulators of gastrointestinal functions
Digestants （助消化药）
Pepsin （胃蛋白酶）Pancreatin （胰酶）Lactasin （乳酶生）：乳酸杆菌制剂Carnitine （肉碱，卡尼丁）
38
AntiemeticsH1 receptor antagonists: diphenhydramine 苯海拉明 ;
dimenhydrinate 茶苯海明 ; meclozine 美克洛嗪Muscarinic receptor antagonists: scopolamine 东莨菪碱
D2 receptor antagonists: chlorpromazine 氯丙嗪，metoclopramide 甲氧氯普胺， domperidone多潘立酮（吗丁啉）
5-HT3 receptor antagonists ： ondansetron 昂丹司琼 ;
grasetron 格拉司琼 ; tropisetron 托烷司琼
Modulators of gastrointestinal functions
39
GI tract smooth muscle cells
NANCneuron
Postganglionic primary motor neuron
Prokinetic drugs
Metoclopramide甲氧氯普胺
( - )
(Central or peripheral)
40
Metoclopramide 甲氧氯普胺
Mechanism of action
1) A 5-HT4 receptor agonist and 5-HT3 receptor antagonist, enhances coordinated transmission in cholinergic nerve plexus
2) A D2 receptor antagonist
Clinical uses
1) Used for treatment of diabetic gastroparesis ( 胃瘫 )2) Used for the prevention of nausea and vomiting
associated with cancer chemotherapy or occurring post-operatively.
41
Adverse effects
1) Fatigue, dizziness, faintness
2) Various extrapyramidal syndromes 锥体外系综合征 :
Parkinsonism 帕金森症 (reversible)
tardive dyskinesia 迟发性运动障碍 (irreversible)
3) Increased serum prolactin 催乳素 levels (chronic
uses)
Metoclopramide 甲氧氯普胺
42
Anti-diarrheals 止泻药
Causes of diarrhea:1) An increase in the active secretion, or an inhibition of absorption
2) Abnormally high motility 43
1. Antimotility drugs ( 胃肠动力抑制药 )
2. Astringents ( 收敛药 )
3. Absorbants ( 吸附药 )
Mechanisms: Agonists for receptors in GI tract
(1) Opium preparations
(2) Diphenoxylate 地芬诺酯： dose not cross the
blood-brain-barrier as easily as most opioids and is
relatively selective for peripheral opioid receptors.
(3) Loperamine 洛哌丁胺： more potent, rapid and
longer than diphenoxylate, without analgesic effects.
Antimotility drugs
44
Astringents 收敛药 Mechanism: astriction
(1) Tannalbin 鞣酸蛋白
(2) Bismuch subsalicylate; bismuch
subcarbonate ( 铋制剂 )
Absorbents 吸附药 (1) Medical charchol 药用炭（活性炭） (2) Agysical 矽炭银（活性炭 + 白陶土） 45
Modulators of gastrointestinal functions
Constipation便秘 :
Treatment
1) Increase the intake of fluids and dietary fiber
3) Laxatives
2) Physical intervention, regular exercise
An decrease in the active secretion, or an enhancement of absorption
Laxatives 泻药
46
2. Laxatives that work osmotically 渗透性泻药
3. Laxatives that decrease absorption 润滑性泻药
Laxatives 泻药
1. Laxatives that increase secretion 刺激性泻药
47
Phenolphthalein 酚酞 ( No longer used because of concerns about carcigenicity)
Bisacodyl 必沙可啶 (It is active after deacetylation, inhibits Na+/K+-ATPase and
increases the synthesis and release of PGE2)
1. Laxatives that increase secretion
Laxatives
48
1. Laxatives that increase secretion
Anthraquinones 蒽醌类（中药成分） Glycoside conjugates free anthraquinone active anthral form
Inhibiting colonic mucosal Na+/K+-ATPase
Rhamnus ( 鼠李 ) Rhubarb ( 大黄 ) Senna ( 番泻叶 )
Laxatives
49
2. Laxatives that work osmotically
1) Salt laxatives: magnesium sulfate 硫酸镁 ; sodium sulfate 硫酸钠；
These agents contain ions that are only slowly
absorbed from the intestine. These ions retain fluid in
the bowel lumen and cause a large volume of fluid to
enter the colon.
Laxatives
50
2. Laxatives that work osmotically
2) Lactulose 乳果糖 ;
In the small bowel, it is resistant to hydrolysis and has an osmotic effect.In the large intestine, lactulose is acted upon by the endogenous flora with the production of lactic acid 乳酸 , Lactic acid also has an osmotic effect.
It is used to reduce ammonia blood levels in the prevention and treatment of hepatic encephalopathy
Laxatives
51
3. Laxatives that decrease absorption
Liquid petrolatum 液体石蜡( Lubricate 润滑 the fecal mass, prevent excessive dehydration of the material, and may inhibit water reabsorption by coating the gut wall)
Laxatives
52
Modulators of gastrointestinal functions
Choleretics （利胆药）Ursodeoxycholic acid （熊去氧胆酸）Dehydrocholic acid （去氢胆酸）Chenodeoxycholic acid （鹅去氧胆酸）Magnesium sulfate （硫酸镁）
53
